Meda Pharma's azelastine follow-on has seen more success launching prior to patent expiry and Meda Pharma is now combining the drug with a steroid. |
|
The Food and Drug Administration requested more information on a new formulation of azelastine hydrochloride nasal spray, Meda said in a statement. |
|